Status:
NOT_YET_RECRUITING
Digital Implementation Support to Achieve Uptake and Integration of Task-Shared Care for Schizophrenia in Primary Care in India
Lead Sponsor:
Harvard Medical School (HMS and HSDM)
Collaborating Sponsors:
Beth Israel Deaconess Medical Center
Sangath
Conditions:
Schizophrenia
Schizophrenia and Related Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Schizophrenia represents a significant contributor to the global burden of disease, with this burden disproportionately impacting low- and middle-income countries (LMICs). In India, the burden due to ...
Detailed Description
Schizophrenia is one of the leading causes of disability due to mental disorders in low-income and middle-income countries (LMICs), such as India, with this burden disproportionately impacting lower i...
Eligibility Criteria
Inclusion
- Primary diagnosis of schizophrenia per IDC-10 diagnostic criteria for research and an illness duration of greater than 12 months and overall moderate level of severity on the CGI-SCH scale
- At least one risk factor for early mortality (e.g. hypertension, diabetes, dyslipidemia, etc)
- Willingness to stay in the study area during the trial period
- Ability to operate a smartphone
Exclusion
- Major visual impairment or inability to operate a smartphone
- Cognitive impairment or diagnosis of dementia
- Planning to move out of the study area in the next 12 months
- Does not speak Hindi or Kannada
Key Trial Info
Start Date :
November 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2029
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06043778
Start Date
November 1 2025
End Date
March 1 2029
Last Update
October 18 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.